New COVID-19 drug with horse antibodies | Fusion - WeRIndia

New COVID-19 drug with horse antibodies

New COVID-19 drug with horse antibodies

The COVID-19 pandemic affected the lives of people across the globe. As of now, there are no effective drugs to treat it. However, a drug regimen is followed by doctors as per the recommendations of regulatory bodies to subside the effects of COVID-19.

Meanwhile, many drug manufacturers are testing a few drugs for COVID-19. Some of them have been approved by the authorities for emergency use to treat COVID-19 patients.

Initially, Hydroxychloroquine was believed to treat COVID-19 and used as prophylactic. Favipiravir was also used to treat COVID-19 patients. Remdesivir was approved by FDA to treat hospitalized patients.

MethylPrednisolone, Dexamethasone, Tocilizumab and Ivermectin are used in India for COVID-19 treatment. DRDO’s 2-Deoxy-D-Glucose (2-DG) was also approved for emergency use as an adjunct therapy.

Now, iSera Biologicals is testing another drug made from horse antibodies for COVID-19. This Kolhapur-based company says that the new drug is effective enough to cure COVID-19 patients in just 90 hours. It claims that patients who used this drug got their RT-PCR report negative within 72 to 90 hours.

iSera Biologicals says that the drug will be beneficial for patients with mild and moderate symptoms.

Currently, the drug is under the first phase of clinical trials. This indigenously made drug will be the first of its kind if it is proven to be effective against COVID-19 in all its clinical trials.

Serum Institute of India, Pune, helped iSera Biologicals to make the anti-COVID drug.

Meanwhile, vaccination has been going on in the country. However, some states are facing a vaccine shortage.

At the same time, the number of new cases has been increasing slowly for the past few days. As per sources, some fully vaccinated people also tested positive for COVID-19. In Kerala, around 40,000 such cases have been reported. The Centre asked the state to send samples of all such breakthrough infected cases for genome sequencing.

Photo by Bicanski on Pixnio (Free for commercial use / CC0 Public Domain)

Image Reference:

Leave a Reply

Your email address will not be published. Required fields are marked *